Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.

N Engl J Med

From the Fred Hutchinson Cancer Research Center and the University of Washington - both in Seattle (G.H.L.); the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, National Academies of Sciences, Engineering, and Medicine, Washington, DC (G.H.L., H.L.M.); and Vanderbilt University, Nashville (H.L.M.).

Published: July 2016

Download full-text PDF	Source
http://dx.doi.org/10.1056/NEJMp1604033	DOI Listing

Publication Analysis

Top Keywords

biomarker tests

tests molecularly

molecularly targeted

targeted therapies--the

therapies--the key

key unlocking

unlocking precision

precision medicine

biomarker

molecularly

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!